Articles
-
Create a U.S. Institute of Health Technology Assessment to Preserve Innovation and Control Costs
Americans need affordable, accessible and innovative health care. An important first step that can be taken without risking heavy-handed intervention is for Congress to establish an independent Institute of Health Technology Assessment.
Categorized in -
Improving and Accelerating Vaccine Distribution
COVID-19 vaccine distribution could be improved by better reliance on community organizations and pharmacies, and by rewarding those entities that do the job better, according to an expert panel convened for a Richard N. Merkin, MD Distinguished Speaker Series webinar.Â
-
Access to Cholesterol-Lowering Drugs Worse in Latino Neighborhoods with High Noncitizen Share
Schaeffer Center experts finds that predominantly Latino neighborhoods with large noncitizen populations have much higher rates of nonadherence to cholesterol-lowering drugs than similar neighborhoods with fewer noncitizens.
Categorized in -
As States Move to Legalize Cannabis, Potency Left Unregulated
Single-use purchase limits of cannabis in states that have legalized typically allow for enough THC to supply a daily user for an entire month or more.
Categorized in -
COVID-19 Is on the Run — Expect the Pandemic to Be Under Control by Memorial Day
Rising immunity from vaccines and prior exposure means we should have COVID-19 cornered by Memorial Day. That doesn’t mean the virus will be out of our lives. But its impact should be reduced to something approaching a normal flu season in terms of deaths and hospitalizations.
Categorized in -
USC Schaeffer Center and Aspen Institute Advisory Panel Recommend Ways to Modernize Health Technology Assessment in the U.S.
The U.S. has no public organization dedicated to producing and evaluating HTAs despite the potential of HTAs providing critical input about price and value, while also recognizing the contribution of innovation to advancing health and healthcare.
-
Monthly Cost Sharing Doubles Throughout the Year for Some Medicare Insulin Users
Schaeffer Center researchers examined how use of insulin changes as cost-sharing fluctuates over the course of the year for Medicare Part D beneficiaries.
-
The Best Vaccination Strategy is Simple: Focus on Americans 65 and Older
The most ethically justified path forward for COVID-19 vaccine distribution is to focus on individuals 65 and older. This group accounts for 80% of COVID-19 deaths despite making up only 16% of the population.
Categorized in -
Reducing Administrative Waste in the US Health Care System
Eliminating administrative expense has the benefit of lowering health care costs without affecting spending on patient care.
Categorized in -
Those Previously Infected with COVID-19 Should Delay Getting a Vaccination
Policymakers should ask the millions of people who have already survived the coronavirus infection to step to the back of the line for vaccines, argue Neeraj Sood and colleagues in CalMatters.
Categorized in